StockData
Bio-Rad Laboratories, Inc. logo

Bio-Rad Laboratories, Inc. (BIO.B) stock

BIO.BNYSELaboratory Analytical InstrumentsFiscal year ends December 31Also trades as BIO
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 8/3055% above fair value
$379.50+0.00 (0.00%)

Close on Oct 29, 2026Market cap $10.18BP/E 46.2Yield –

Bio-Rad Laboratories shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Bio-Rad Laboratories's shares outstanding was 27M at Jun 30, 2026. For fiscal 2025 it was 27M, down 3.3% from the year before. Over ten years it grew -0.7% a year on average. The highest annual figure on record is 30M in fiscal 2018.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202527M-3.3%
FY2024Dec 31, 202428M-3.4%
FY2023Dec 31, 202329M-1.9%
FY2022Dec 31, 202230M-1.4%
FY2021Dec 31, 202130M+0.2%
FY2020Dec 31, 202030M-0.1%
FY2019Dec 31, 201930M-0.1%
FY2018Dec 31, 201830M+0.6%
FY2017Dec 31, 201730M+1.3%
FY2016Dec 31, 201630M+0.8%
FY2015Dec 31, 201529M+0.9%
FY2014Dec 31, 201429M+0.8%
FY2013Dec 31, 201329M+0.9%
FY2012Dec 31, 201229M+0.6%
FY2011Dec 31, 201128M+1.1%
FY2010Dec 31, 201028M+1.2%
FY2009Dec 31, 200928M+0.7%
FY2008Dec 31, 200828M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202627M-1.5%
Q1 FY2026Mar 31, 202627M-3.6%
Q4 FY2025Dec 31, 202527M-3.5%
Q3 FY2025Sep 30, 202527M-3.8%
Q2 FY2025Jun 30, 202527M-4.1%
Q1 FY2025Mar 31, 202528M-2.0%
Q4 FY2024Dec 31, 202428M-2.7%
Q3 FY2024Sep 30, 202428M-4.2%
Q2 FY2024Jun 30, 202428M-3.3%
Q1 FY2024Mar 31, 202429M-4.1%
Q4 FY2023Dec 31, 202329M-3.0%
Q3 FY2023Sep 30, 202329M-1.7%
Q2 FY2023Jun 30, 202329M-1.5%
Q1 FY2023Mar 31, 202330M-0.6%
Q4 FY2022Dec 31, 202230M-1.9%
Q3 FY2022Sep 30, 202230M-1.6%
Q2 FY2022Jun 30, 202230M-1.2%
Q1 FY2022Mar 31, 202230M-0.8%
Q4 FY2021Dec 31, 202130M+0.1%
Q3 FY2021Sep 30, 202130M+0.3%
Q2 FY2021Jun 30, 202130M+0.3%
Q1 FY2021Mar 31, 202130M-0.0%
Q4 FY2020Dec 31, 202030M-0.2%
Q3 FY2020Sep 30, 202030M+1.0%
Q2 FY2020Jun 30, 202030M-0.3%
Q1 FY2020Mar 31, 202030M+0.3%
Q4 FY2019Dec 31, 201930M+0.3%
Q3 FY2019Sep 30, 201930M-1.5%
Q2 FY2019Jun 30, 201930M-0.2%
Q1 FY2019Mar 31, 201930M-0.2%
Q4 FY2018Dec 31, 201830M+0.2%
Q3 FY2018Sep 30, 201830M+0.8%
Q2 FY2018Jun 30, 201830M+0.7%
Q1 FY2018Mar 31, 201830M+0.9%
Q4 FY2017Dec 31, 201730M+1.2%
Q3 FY2017Sep 30, 201730M+1.3%
Q2 FY2017Jun 30, 201730M–
Q1 FY2017Mar 31, 201730M–
Q4 FY2016Dec 31, 201630M–
Q3 FY2016Sep 30, 201630M–

More Bio-Rad Laboratories figures